Global Bioengineered Protein Drugs Market by Manufacturers, Regions, Type and Application, Forecast to 2023

2018-06-13 / 3150.00 / Chemical & Materials / 114 Pages

Description

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Bioengineered Protein Drugs in these regions, from 2012 to 2023 (forecast), covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Bioengineered Protein Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
GlaxoSmithKline
Johnson & Johnson
Merck
Novartis
Sanofi
Eli Lilly
F. Hoffmann-La Roche
Dr. Reddy's Laboratories
Abbott Laboratories
Amgen
Bayer AG
Biocon
Fresenius kabi
Panacea Biotec
ProBioGen AG
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Monoclonal Antibodies
Therapeutic Proteins
Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Bioengineered Protein Drugs for each application, including
Pharma and Biotech Companies
CROs
Academics

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Content

Table of Contents

Global Bioengineered Protein Drugs Market by Manufacturers, Regions, Type and Application, Forecast to 2023
1 Market Overview
1.1 Bioengineered Protein Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Monoclonal Antibodies
1.2.2 Therapeutic Proteins
1.2.3 Vaccines
1.3 Market Analysis by Applications
1.3.1 Pharma and Biotech Companies
1.3.2 CROs
1.3.3 Academics
1.4 New Project SWOT Analysis of Bioengineered Protein Drugs
1.5 Industry News Analysis of Bioengineered Protein Drugs

2 Industrial Chain Analysis
2.1 Industry Chain Structure of Bioengineered Protein Drugs
2.2 Raw Material Analysis of Bioengineered Protein Drugs
2.2.1 Raw Material A Market Analysis
2.2.2 Raw Material B Market Analysis
2.2.3 Raw Material C Market Analysis
2.3 Labor Cost Analysis of Bioengineered Protein Drugs
2.4 Other Costs Analysis of Bioengineered Protein Drugs
2.5 Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs
2.6 Manufacturing Process Analysis of Bioengineered Protein Drugs
2.7 Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2017
2.8 Downstream Buyers of Bioengineered Protein Drugs

3 Global Bioengineered Protein Drugs Players Profiles and Sales Data
3.1 GlaxoSmithKline
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Bioengineered Protein Drugs Product Category, Application and Specification
3.1.2.1 Monoclonal Antibodies
3.1.2.2 Therapeutic Proteins
3.1.2.3 Vaccines
3.1.3 GlaxoSmithKline Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.1.4 GlaxoSmithKline Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.1.5 GlaxoSmithKline Bioengineered Protein Drugs Volume in Different Applications and Its Application Share
3.2 Johnson & Johnson
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Bioengineered Protein Drugs Product Category, Application and Specification
3.2.2.1 Monoclonal Antibodies
3.2.2.2 Therapeutic Proteins
3.2.2.3 Vaccines
3.2.3 Johnson & Johnson Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.2.4 Johnson & Johnson Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.2.5 Johnson & Johnson Bioengineered Protein Drugs Volume in Different Applications and Its Application Share
3.3 Merck
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Bioengineered Protein Drugs Product Category, Application and Specification
3.3.2.1 Monoclonal Antibodies
3.3.2.2 Therapeutic Proteins
3.3.2.3 Vaccines
3.3.3 Merck Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.3.4 Merck Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.3.5 Merck Bioengineered Protein Drugs Volume in Different Applications and Its Application Share
3.4 Novartis
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Bioengineered Protein Drugs Product Category, Application and Specification
3.4.2.1 Monoclonal Antibodies
3.4.2.2 Therapeutic Proteins
3.4.2.3 Vaccines
3.4.3 Novartis Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.4.4 Novartis Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.4.5 Novartis Bioengineered Protein Drugs Volume in Different Applications and Its Application Share
3.5 Sanofi
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Bioengineered Protein Drugs Product Category, Application and Specification
3.5.2.1 Monoclonal Antibodies
3.5.2.2 Therapeutic Proteins
3.5.2.3 Vaccines
3.5.3 Sanofi Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.5.4 Sanofi Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.5.5 Sanofi Bioengineered Protein Drugs Volume in Different Applications and Its Application Share
3.6 Eli Lilly
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Bioengineered Protein Drugs Product Category, Application and Specification
3.6.2.1 Monoclonal Antibodies
3.6.2.2 Therapeutic Proteins
3.6.2.3 Vaccines
3.6.3 Eli Lilly Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.6.4 Eli Lilly Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.6.5 Eli Lilly Bioengineered Protein Drugs Volume in Different Applications and Its Application Share
3.7 F. Hoffmann-La Roche
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Bioengineered Protein Drugs Product Category, Application and Specification
3.7.2.1 Monoclonal Antibodies
3.7.2.2 Therapeutic Proteins
3.7.2.3 Vaccines
3.7.3 F. Hoffmann-La Roche Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.7.4 F. Hoffmann-La Roche Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.7.5 F. Hoffmann-La Roche Bioengineered Protein Drugs Volume in Different Applications and Its Application Share
3.8 Dr. Reddy's Laboratories
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Bioengineered Protein Drugs Product Category, Application and Specification
3.8.2.1 Monoclonal Antibodies
3.8.2.2 Therapeutic Proteins
3.8.2.3 Vaccines
3.8.3 Dr. Reddy's Laboratories Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.8.4 Dr. Reddy's Laboratories Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.8.5 Dr. Reddy's Laboratories Bioengineered Protein Drugs Volume in Different Applications and Its Application Share
3.9 Abbott Laboratories
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Bioengineered Protein Drugs Product Category, Application and Specification
3.9.2.1 Monoclonal Antibodies
3.9.2.2 Therapeutic Proteins
3.9.2.3 Vaccines
3.9.3 Abbott Laboratories Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.9.4 Abbott Laboratories Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.9.5 Abbott Laboratories Bioengineered Protein Drugs Volume in Different Applications and Its Application Share
3.10 Amgen
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Bioengineered Protein Drugs Product Category, Application and Specification
3.10.2.1 Monoclonal Antibodies
3.10.2.2 Therapeutic Proteins
3.10.2.3 Vaccines
3.10.3 Amgen Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.10.4 Amgen Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.10.5 Amgen Bioengineered Protein Drugs Volume in Different Applications and Its Application Share
3.11 Bayer AG
3.12 Biocon
3.13 Fresenius kabi
3.14 Panacea Biotec
3.15 ProBioGen AG

4 Global Bioengineered Protein Drugs Market Competition by Manufacturers
4.1 Global Bioengineered Protein Drugs Sales and Share by Manufacturers (2012-2017)
4.2 Global Bioengineered Protein Drugs Revenue (Million USD) and Share (%) by Manufacturers (2012-2017)
4.3 Market Concentration Rate
4.3.1 Top 3 Bioengineered Protein Drugs Manufacturer Market Share
4.3.2 Top 6 Bioengineered Protein Drugs Manufacturer Market Share
4.4 Market Competition Trend

5 Global Bioengineered Protein Drugs Market Analysis by Regions
5.1 Global Bioengineered Protein Drugs Sales, Revenue and Market Share by Regions
5.1.1 Global Bioengineered Protein Drugs Sales by Regions (2012-2017)
5.1.2 Global Bioengineered Protein Drugs Revenue by Regions (2012-2017)
5.2 North America Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
5.3 Europe Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
5.4 Asia-Pacific Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
5.5 South America Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
5.6 Middle East and Africa Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)

6 North America Bioengineered Protein Drugs by Countries
6.1 North America Bioengineered Protein Drugs Sales, Revenue and Market Share by Countries
6.1.1 North America Bioengineered Protein Drugs Sales by Countries (2012-2017)
6.1.2 North America Bioengineered Protein Drugs Revenue by Countries (2012-2017)
6.2 United States Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
6.3 Canada Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
6.4 Mexico Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)

7 Europe Bioengineered Protein Drugs by Countries
7.1 North America Bioengineered Protein Drugs Sales, Revenue and Market Share by Countries
7.1.1 Europe Bioengineered Protein Drugs Sales by Countries (2012-2017)
7.1.2 Europe Bioengineered Protein Drugs Sales by Countries (2012-2017)
7.2 Germany Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
7.3 France Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
7.4 UK Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
7.5 Russia Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
7.6 Italy Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)

8 Asia-Pacific Bioengineered Protein Drugs by Countries
8.1 Asia-Pacific Bioengineered Protein Drugs Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Bioengineered Protein Drugs Sales by Countries (2012-2017)
8.1.2 Asia-Pacific Bioengineered Protein Drugs Sales by Countries (2012-2017)
8.2 China Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
8.3 Japan Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
8.4 Korea Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
8.5 India Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
8.6 Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)

9 South America Bioengineered Protein Drugs by Countries
9.1 South America Bioengineered Protein Drugs Sales, Revenue and Market Share by Countries
9.1.1 South America Bioengineered Protein Drugs Sales by Countries (2012-2017)
9.1.2 South America Bioengineered Protein Drugs Sales by Countries (2012-2017)
9.2 Brazil Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
9.3 Argentina Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
9.4 Columbia Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)

10 Middle East and Africa Bioengineered Protein Drugs by Countries
10.1 Middle East and Africa Bioengineered Protein Drugs Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Bioengineered Protein Drugs Sales by Countries (2012-2017)
10.1.2 Middle East and Africa Bioengineered Protein Drugs Sales by Countries (2012-2017)
10.2 Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
10.3 UAE Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
10.4 Egypt Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
10.5 Nigeria Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
10.6 South Africa Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)

11 Global Bioengineered Protein Drugs Market Segment by Type
11.1 Global Bioengineered Protein Drugs Sales, Revenue and Market Share by Type (2012-2017)
11.1.1 Global Bioengineered Protein Drugs Sales and Market Share by Type (2012-2017)
11.1.2 Global Bioengineered Protein Drugs Revenue and Market Share by Type (2012-2017)
11.2 Monoclonal Antibodies Sales Growth Rate and Price
11.2.1 Global Monoclonal Antibodies Sales Growth Rate (2012-2017)
11.2.2 Global Monoclonal Antibodies Price (2012-2017)
11.3 Therapeutic Proteins Sales Growth Rate and Price
11.3.1 Global Therapeutic Proteins Sales Growth Rate (2012-2017)
11.3.2 Global Therapeutic Proteins Price (2012-2017)
11.4 Vaccines Sales Growth Rate and Price
11.4.1 Global Vaccines Sales Growth Rate (2012-2017)
11.4.2 Global Vaccines Price (2012-2017)
11.5 Sales Growth Rate and Price
11.5.1 Global Sales Growth Rate (2012-2017)
11.5.2 Global Price (2012-2017)
11.6 Sales Growth Rate and Price
11.6.1 Global Sales Growth Rate (2012-2017)
11.6.2 Global Price (2012-2017)

12 Global Bioengineered Protein Drugs by Application
12.1 Global Bioengineered Protein Drugs Sales Market Share by Application (2012-2017)
12.2 Pharma and Biotech Companies Sales Growth Rate (2012-2017)
12.3 CROs Sales Growth Rate (2012-2017)
12.4 Academics Sales Growth Rate (2012-2017)
12.5 Sales Growth Rate (2012-2017)
12.6 Sales Growth Rate (2012-2017)

13 Global Bioengineered Protein Drugs Market Forecast (2018-2023)
13.1 Global Bioengineered Protein Drugs Sales Volume, Revenue and Price Forecast (2018-2023)
13.1.1 Global Bioengineered Protein Drugs Sales Volume and Growth Rate Forecast (2018-2023)
13.1.2 Global Bioengineered Protein Drugs Revenue and Growth Rate Forecast (2018-2023)
13.1.3 Global Bioengineered Protein Drugs Price and Trend Forecast (2018-2023)
13.2 Global Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2023)
13.2.1 Global Bioengineered Protein Drugs Sales Volume and Growth Rate Forecast by Regions (2018-2023)
13.2.2 Global Bioengineered Protein Drugs Revenue and Growth Rate Forecast by Regions (2018-2023)
13.2.3 Global Bioengineered Protein Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
13.2.4 North America (United States, Canada and Mexico) Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
13.2.5 Europe (Germany, France, UK, Russia and Italy) Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
13.2.6 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
13.2.7 South America (Brazil, Argentina, Columbia) Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
13.2.8 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
13.3 Global Bioengineered Protein Drugs Sales Volume, Revenue and Price Forecast by Type (2018-2023)
13.3.1 Global Bioengineered Protein Drugs Sales Forecast by Type (2018-2023)
13.3.2 Global Bioengineered Protein Drugs Revenue Forecast by Type (2018-2023)
13.3.3 Global Bioengineered Protein Drugs Price Forecast by Type (2018-2023)
13.4 Global Bioengineered Protein Drugs Sales Volume Forecast by Application (2018-2023)
13.4.1 Global Bioengineered Protein Drugs Sales Forecast by Application (2018-2023)
13.4.2 Global Bioengineered Protein Drugs Market Share Forecast by Application (2018-2023)

14 Sales Channel, Distributors, Traders and Dealers
14.1 Sales Channel
14.1.1 Direct Marketing
14.1.2 Indirect Marketing
14.1.3 Marketing Channel Future Trend
14.2 Distributors, Traders and Dealers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.2 Analyst Introduction
16.3 Data Source



Table of Figures

List of Tables and Figures

Figure Bioengineered Protein Drugs Picture
Table Product Specifications of Bioengineered Protein Drugs
Figure Global Sales Market Share of Bioengineered Protein Drugs by Types in 2017
Table Bioengineered Protein Drugs Types for Major Manufacturers
Figure Monoclonal Antibodies Picture
Figure Therapeutic Proteins Picture
Figure Vaccines Picture
Figure Bioengineered Protein Drugs Sales Market Share by Applications in 2017
Figure Pharma and Biotech Companies Picture
Figure CROs Picture
Figure Academics Picture
Figure New Project SWOT Analysis of Bioengineered Protein Drugs
Table Industry News List of Bioengineered Protein Drugs
Figure Industry Chain Structure of Bioengineered Protein Drugs
Table Raw Material Suppliers and Price Analysis
Figure Global Raw Material A Price Trend (USD/MT)
Figure Global Raw Material B Price Trend (USD/MT)
Figure Global Raw Material C Price Trend (USD/MT)
Table Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs in 2017
Figure Manufacturing Process Analysis of Bioengineered Protein Drugs
Table Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2017
Table Major Buyers of Bioengineered Protein Drugs
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure GlaxoSmithKline Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017)
Figure GlaxoSmithKline Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017)
Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table GlaxoSmithKline Bioengineered Protein Drugs Volume in Pharma and Biotech Companies and Its Application Share
Table GlaxoSmithKline Bioengineered Protein Drugs Volume in CROs and Its Application Share
Table GlaxoSmithKline Bioengineered Protein Drugs Volume in Academics and Its Application Share
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Johnson & Johnson Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017)
Figure Johnson & Johnson Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017)
Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Johnson & Johnson Bioengineered Protein Drugs Volume in Pharma and Biotech Companies and Its Application Share
Table Johnson & Johnson Bioengineered Protein Drugs Volume in CROs and Its Application Share
Table Johnson & Johnson Bioengineered Protein Drugs Volume in Academics and Its Application Share
Table Merck Basic Information List
Table Merck Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Merck Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Merck Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017)
Figure Merck Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017)
Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Merck Bioengineered Protein Drugs Volume in Pharma and Biotech Companies and Its Application Share
Table Merck Bioengineered Protein Drugs Volume in CROs and Its Application Share
Table Merck Bioengineered Protein Drugs Volume in Academics and Its Application Share
Table Novartis Basic Information List
Table Novartis Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Novartis Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Novartis Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017)
Figure Novartis Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017)
Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Novartis Bioengineered Protein Drugs Volume in Pharma and Biotech Companies and Its Application Share
Table Novartis Bioengineered Protein Drugs Volume in CROs and Its Application Share
Table Novartis Bioengineered Protein Drugs Volume in Academics and Its Application Share
Table Sanofi Basic Information List
Table Sanofi Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Sanofi Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Sanofi Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017)
Figure Sanofi Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017)
Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Sanofi Bioengineered Protein Drugs Volume in Pharma and Biotech Companies and Its Application Share
Table Sanofi Bioengineered Protein Drugs Volume in CROs and Its Application Share
Table Sanofi Bioengineered Protein Drugs Volume in Academics and Its Application Share
Table Eli Lilly Basic Information List
Table Eli Lilly Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Eli Lilly Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017)
Figure Eli Lilly Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017)
Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Eli Lilly Bioengineered Protein Drugs Volume in Pharma and Biotech Companies and Its Application Share
Table Eli Lilly Bioengineered Protein Drugs Volume in CROs and Its Application Share
Table Eli Lilly Bioengineered Protein Drugs Volume in Academics and Its Application Share
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure F. Hoffmann-La Roche Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017)
Figure F. Hoffmann-La Roche Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017)
Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table F. Hoffmann-La Roche Bioengineered Protein Drugs Volume in Pharma and Biotech Companies and Its Application Share
Table F. Hoffmann-La Roche Bioengineered Protein Drugs Volume in CROs and Its Application Share
Table F. Hoffmann-La Roche Bioengineered Protein Drugs Volume in Academics and Its Application Share
Table Dr. Reddy's Laboratories Basic Information List
Table Dr. Reddy's Laboratories Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Dr. Reddy's Laboratories Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Dr. Reddy's Laboratories Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017)
Figure Dr. Reddy's Laboratories Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017)
Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Dr. Reddy's Laboratories Bioengineered Protein Drugs Volume in Pharma and Biotech Companies and Its Application Share
Table Dr. Reddy's Laboratories Bioengineered Protein Drugs Volume in CROs and Its Application Share
Table Dr. Reddy's Laboratories Bioengineered Protein Drugs Volume in Academics and Its Application Share
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Abbott Laboratories Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017)
Figure Abbott Laboratories Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017)
Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Abbott Laboratories Bioengineered Protein Drugs Volume in Pharma and Biotech Companies and Its Application Share
Table Abbott Laboratories Bioengineered Protein Drugs Volume in CROs and Its Application Share
Table Abbott Laboratories Bioengineered Protein Drugs Volume in Academics and Its Application Share
Table Amgen Basic Information List
Table Amgen Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Amgen Bioengineered Protein Drugs Sales Growth Rate (2012-2017)
Figure Amgen Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017)
Figure Amgen Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017)
Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Amgen Bioengineered Protein Drugs Volume in Pharma and Biotech Companies and Its Application Share
Table Amgen Bioengineered Protein Drugs Volume in CROs and Its Application Share
Table Amgen Bioengineered Protein Drugs Volume in Academics and Its Application Share
Table Global Bioengineered Protein Drugs Sales by Manufacturer (2016-2017)
Figure Global Bioengineered Protein Drugs Sales Market Share by Manufacturer in 2016
Figure Global Bioengineered Protein Drugs Sales Market Share by Manufacturer in 2017
Table Global Bioengineered Protein Drugs Revenue by Manufacturer (2016-2017)
Figure Global Bioengineered Protein Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Bioengineered Protein Drugs Revenue Market Share by Manufacturer in 2017
Figure Top 3 Bioengineered Protein Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Bioengineered Protein Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure Global Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
Table Global Bioengineered Protein Drugs Sales by Regions (2012-2017)
Table Global Bioengineered Protein Drugs Sales Market Share by Regions (2012-2017)
Table Global Bioengineered Protein Drugs Revenue by Regions (2012-2017)
Table Global Bioengineered Protein Drugs Revenue Market Share by Regions in 2012
Table Global Bioengineered Protein Drugs Revenue Market Share by Regions in 2017
Figure North America Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure Europe Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure Asia-Pacific Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure South America Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure Middle East and Africa Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure North America Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
Table North America Bioengineered Protein Drugs Sales by Countries (2012-2017)
Table North America Bioengineered Protein Drugs Sales Market Share by Countries (2012-2017)
Figure North America Bioengineered Protein Drugs Sales Market Share by Countries in 2012
Figure North America Bioengineered Protein Drugs Sales Market Share by Countries in 2017
Table North America Bioengineered Protein Drugs Revenue by Countries (2012-2017)
Table North America Bioengineered Protein Drugs Revenue Market Share by Countries (2012-2017)
Figure North America Bioengineered Protein Drugs Revenue Market Share by Countries in 2012
Figure North America Bioengineered Protein Drugs Revenue Market Share by Countries in 2017
Figure United States Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure Canada Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure Mexico Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure Europe Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
Table Europe Bioengineered Protein Drugs Sales by Countries (2012-2017)
Table Europe Bioengineered Protein Drugs Sales Market Share by Countries (2012-2017)
Table Europe Bioengineered Protein Drugs Revenue by Countries (2012-2017)
Table Europe Bioengineered Protein Drugs Revenue Market Share by Countries in 2012
Table Europe Bioengineered Protein Drugs Revenue Market Share by Countries in 2017
Figure Germany Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure UK Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure France Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure Russia Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure Italy Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure Asia-Pacific Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Sales by Countries (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Revenue by Countries (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Revenue Market Share by Countries (2012-2017)
Figure China Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure Japan Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure Korea Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure India Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure Southeast Asia Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure South America Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
Table South America Bioengineered Protein Drugs Sales by Countries (2012-2017)
Table South America Bioengineered Protein Drugs Sales Market Share by Countries (2012-2017)
Figure South America Bioengineered Protein Drugs Sales Market Share by Countries in 2017
Table South America Bioengineered Protein Drugs Revenue by Countries (2012-2017)
Table South America Bioengineered Protein Drugs Revenue Market Share by Countries (2012-2017)
Figure South America Bioengineered Protein Drugs Revenue Market Share by Countries in 2017
Figure Brazil Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure Argentina Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure Columbia Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure Middle East and Africa Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
Table Middle East and Africa Bioengineered Protein Drugs Sales by Countries (2012-2017)
Table Middle East and Africa Bioengineered Protein Drugs Sales Market Share by Countries (2012-2017)
Figure Middle East and Africa Bioengineered Protein Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Bioengineered Protein Drugs Revenue by Countries (2012-2017)
Table Middle East and Africa Bioengineered Protein Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East and Africa Bioengineered Protein Drugs Revenue Market Share by Countries in 2012
Figure Middle East and Africa Bioengineered Protein Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure UAE Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure Egypt Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure Nigeria Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Figure South Africa Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
Table Global Bioengineered Protein Drugs Sales by Type (2012-2017)
Table Global Bioengineered Protein Drugs Sales Share by Type (2012-2017)
Table Global Bioengineered Protein Drugs Revenue by Type (2012-2017)
Table Global Bioengineered Protein Drugs Revenue Share by Type (2012-2017)
Figure Global Monoclonal Antibodies Sales Growth Rate (2012-2017)
Figure Global Monoclonal Antibodies Sales Price (2012-2018)
Figure Global Monoclonal Antibodies Sales Growth Rate (2012-2017)
Figure Global Therapeutic Proteins Sales Price (2012-2018)
Figure Global Vaccines Sales Growth Rate (2012-2017)
Figure Global Vaccines Sales Price (2012-2018)
Table Global Bioengineered Protein Drugs Sales by Application (2012-2017)
Table Global Bioengineered Protein Drugs Sales Share by Application (2012-2017)
Figure Global Pharma and Biotech Companies Sales Growth Rate (2012-2017)
Figure Global CROs Sales Growth Rate (2012-2017)
Figure Global Academics Sales Growth Rate (2012-2019)
Figure Global Bioengineered Protein Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Bioengineered Protein Drugs Sales Forecast by Regions (2018-2023)
Table Global Bioengineered Protein Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Bioengineered Protein Drugs Market Forecast (2018-2023)
Figure Europe Sales Bioengineered Protein Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Bioengineered Protein Drugs Market Forecast (2018-2023)
Figure South America Sales Bioengineered Protein Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Bioengineered Protein Drugs Market Forecast (2018-2023)
Table Global Bioengineered Protein Drugs Sales Forecast by Type (2018-2023)
Table Global Bioengineered Protein Drugs Market Share Forecast by Type (2018-2023)
Table Global Bioengineered Protein Drugs Sales Forecast by Application (2018-2023)
Table Global Bioengineered Protein Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
















Request Sample

* mark fields are compulsory